Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -113,535 | -48,542 | -237,734 | -170,874 | -123,214 |
| Depreciation Amortization | -8,784 | -4,395 | -10,968 | -8,051 | -5,647 |
| Accounts payable and accrued liabilities | 920 | 482 | -12,040 | -10,524 | -10,416 |
| Other Working Capital | 6,170 | -4,958 | -9,425 | -15,041 | -10,958 |
| Other Operating Activity | 23,948 | 12,190 | 85,997 | 58,320 | 43,048 |
| Operating Cash Flow | $-91,281 | $-45,223 | $-184,170 | $-146,170 | $-107,187 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -80,965 | -143,045 | -93,354 | 76,309 | 27,864 |
| PPE Investments | -104 | N/A | -898 | -850 | -446 |
| Investing Cash Flow | $-81,069 | $-143,045 | $-94,252 | $75,459 | $27,418 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 15,000 | 15,000 | N/A |
| Common Stock Issued | 187,669 | 187,459 | 146,793 | 12,243 | 11,272 |
| Common Stock Repurchased | -10,479 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -10,377 | 63,877 | -514 | 0 |
| Financing Cash Flow | $177,190 | $177,082 | $225,670 | $26,729 | $11,272 |
| Beginning Cash Position | 102,827 | 102,827 | 155,579 | 155,579 | 155,579 |
| End Cash Position | 107,667 | 91,641 | 102,827 | 111,597 | 87,082 |
| Net Cash Flow | $4,840 | $-11,186 | $-52,752 | $-43,982 | $-68,497 |
| Free Cash Flow | |||||
| Operating Cash Flow | -91,281 | -45,223 | -184,170 | -146,170 | -107,187 |
| Capital Expenditure | -104 | N/A | -898 | -850 | -446 |
| Free Cash Flow | -91,385 | -45,223 | -185,068 | -147,020 | -107,633 |